Sierra Ocean’s Celldex Therapeutics CLDX Stock Holding History

Sierra Ocean’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-92	Closed	-$1.67K	–	1053
2025 Q1	$1.67K	Buy	+92	New	+$2.06K	﹤0.01%	815

Other funds holding CLDX

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sierra Ocean's CLDX Position: Q2 2025 in Review

Sierra Ocean sold out of Celldex Therapeutics (CLDX) in Q2 2025, closing a stake of 92 shares — an estimated $1.67K sold.

Sierra Ocean first reported a position in CLDX in Q1 2025 and held it in 1 quarter. The position peaked at $1.67K in Q1 2025. 180 funds tracked by Wall St. Rank hold CLDX as of Q2 2025.

Sierra Ocean reported no remaining Celldex Therapeutics position as of Q2 2025 after selling out during the quarter.
Sierra Ocean sold 92 Celldex Therapeutics shares in Q2 2025, an estimated $1.67K.
Sierra Ocean first reported a position in Celldex Therapeutics in Q1 2025 and held it in 1 quarter.
Sierra Ocean's Celldex Therapeutics position peaked at $1.67K in Q1 2025.
180 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2025.

Based on Sierra Ocean's 13F filing for Q2 2025, filed 7 Aug 2025.